Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132258) titled 'Becotatug Vedotin Combined with Pucotelimab in the Treatment of Advanced EGFR-Positive Penile Cancer' on Sept. 11.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Fudan University Shanghai Cancer Center
Condition:
Recurrent and metastatic squamous cell carcinoma of the penis
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-09-30
Target Sample Size: Intervention group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=338391
Disclaimer: Curated by HT Syndication....